IN AND OUTFLOWS: While one more Apple supplier invested in its China green fund, a local manufacturer’s China branch applied to invest in Taiwan due to the trade war
Date: Sep 25, 2018
By: Ted Chen / Staff reporter
The Ministry of Economic Affairs’ Investment Commission on Friday last week approved a NT$9.35 billion (US$304.40 million) buyout of medical equipment maker Microlife Corp (百略) by an affiliate of Morgan Stanley Private Equity Asia.
Microlife in March announced that it had agreed to sell all of its shares to Midas Health Co Ltd at NT$84.74 per share, a 17.85 percent premium over the stock’s 20-day average closing price of NT$71.9.
The company is to be delisted from the local bourse next month, the commission said.
Midas Health is part of a US$1.7 billion closed-end private equity plan under Morgan Stanley. [FULL STORY]